Ethiopia Pharmaceuticals & Healthcare Q1 2020
Poor financing remains a major challenge for Ethiopia's healthcare services and pharmaceutical treatment access. Thedominance of out-of-pocket payments in terms of healthcare and pharmaceutical spending means vulnerability to wider economicfluctuations and also points to few commercial opportunities for multinational drugmakers. At the same time, we expect littleimprovement in the investment climate, given the high level of political instability.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook